400-920-2911 sales@csnpharm.cn
货号 | 产品名 | CAS号 | 信息 |
---|---|---|---|
CSN12120 | TPEN | 16858-02-9 | TPEN is an intracellular membrane-permeable ion chelator, with high-affinity heavy metal (Zn2+>Fe2+>Mn2+) and low affinity for Mg2+ and Ca2+. |
CSN11952 | Sodium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate | 527-07-1 | Sodium Gluconate is the sodium salt of gluconic acid with chelating property. |
CSN23890 | Pyridoxal isonicotinoyl hydrazone | 737-86-0 | Pyridoxal isonicotinoyl hydrazone is a cell-permeable non-toxic iron chelator of the aroyl hydrazone class. |
CSN12738 | (S)-2-Amino-3-mercapto-3-methylbutanoic acid | 52-67-5 | Penicillamine is used as an antirheumatic and as a chelating agent in Wilson's disease. |
CSN25445 | 1,10-Phenanthroline | 66-71-7 | o-Phenanthroline (1,10-Phenanthroline), a metal chelator, prevents the induction of chromosomal aberrations in streptozotocin-treated cells. o-Phenanthroline (1,10-Phenanthroline) forms a red chelate with Fe2+ that absorbs maximally at 510 nm. |
CSN50772 | Enterobactin | 28384-96-5 | Enterobactin is a siderophore produced by Escherichia coli and related gut bacteria. Enterobactin is a very potent iron chelator that easily removes iron from proteins, insoluble iron complexes and other siderophores. |
CSN18770 | Dp44mT | 152095-12-0 | Dp44mT is a potent iron chelator, which shows selective antitumor activity. |
CSN29536 | DOTA-NHS-ester | 170908-81-3 | DOTA-NHS-ester is a linker for affibody molecules and is applied in small animals PET, SPECT, and CT. DOTA-NHS-ester can be used to label radiotherapeutic agents or imaging probes for the detection of tumors. |
CSN25406 | 3-Hydroxy-1,2-dimethylpyridin-4(1H)-one | 30652-11-0 | Deferiprone is the only orally active iron-chelating drug to be used therapeutically in conditions of transfusional iron overload. Target: Deferiprone is an orphan drug designed and developed primarily by academic initiatives for the treatment of iron overload in thalassaemia. Deferiprone has been used in several other iron or other metal imbalance conditions and has prospects of wider clinical applications. Deferiprone has high affinity for iron and interacts with almost all the iron pools at the molecular, cellular, tissue and organ levels. Doses of 50-120 mg/kg/day appear to be effective in bringing patients to negative iron balance. Deferiprone increases urinary iron excretion, which mainly depends on the iron load of patients and the dose of the drug. |
CSN10377 | BAPTA-AM | 126150-97-8 | BAPTA-AM is a selective, membrane-permeable calcium chelator. |
CSN37546 | Tri-tert-butyl 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate | 122555-91-3 | |
CSN39424 | 2-Aminoethyl-mono-amide-DOTA-tris(tBu ester) | 173308-19-5 | |
CSN33413 | DOTA-tris(tBu)ester NHS ester | 819869-77-7 | |
CSN33393 | Polaprezinc | 107667-60-7 | |
CSN43942 | 2-(4,7,10-Tris(2-(tert-butoxy)-2-oxoethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetic acid | 137076-54-1 | |
CSN51497 | Copper(II) disodium 2,2',2'',2'''-(ethane-1,2-diylbis(azanetriyl))tetraacetate tetrahydrate | 39208-15-6 | |
CSN51494 | Manganese(II) disodium 2,2',2'',2'''-(ethane-1,2-diylbis(azanetriyl))tetraacetate | 15375-84-5 | |
CSC51494 | EDTA disodium manganese salt | 15375-84-5 | |
CSN51495 | Ethylenediaminetetraacetic Acid Disodium Zinc Salt | 14025-21-9 | |
CSN51492 | Sodium 2,2'-((2-((carboxylatomethyl)(2-hydroxyethyl)amino)ethyl)azanediyl)diacetate | 139-89-9 | |
CSN51505 | 2,2-((2-((Carboxymethyl)(2-hydroxyethyl)amino)ethyl)azanediyl)diacetic acid | 150-39-0 | |
CSN112306 | Gadoteric acid | 72573-82-1 | |
CSN51556 | (2S,2'S)-2,2'-(Ethane-1,2-diylbis(azanediyl))disuccinic acid | 20846-91-7 | |
CSN51819 | DO3A | 217973-03-0 | |
CSN51834 | Ethylenediaminetetraacetic acid diammonium copper salt | 67989-88-2 | |
CSN51818 | Tris-BOC-Cyclen | 175854-39-4 |